Updated January 14th, 2021

Blood Test Could Predict the Best Type of Treatment for Metastatic Melanoma

A new study finds that people with lower levels of tumor DNA in their blood stream may be better candidates for immune checkpoint inhibitors as a first treatment.

NOW
PLAYING
NFL Coach Ron Rivera on His Skin Cancer Treatment Path
NOW
PLAYING
5 Lessons to Learn from Cindy McCain's New Memoir
NOW
PLAYING
CART T-Cell Therapy During the COVID-19 Pandemic: Is it Safe?
NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
Some Hand Sanitizers Found to Contain Cancer-Causing Compound Benzene; How Cancer Patients Can Protect Themselves During COVID-19
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.